We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

139 hedge funds and large institutions have $2.33B invested in Legend Biotech in 2021 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 14

91% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 23

58% more funds holding

Funds holding: 88 → 139 (+51)

18% more capital invested

Capital invested by funds: $1.97B → $2.33B (+$357M)

2.95% more ownership

Funds ownership: 13.48% → 16.43% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

53% less call options, than puts

Call options by funds: $2.89M | Put options by funds: $6.1M

Holders
139
Holders Change
+51
Holders Change %
+57.95%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
66
Increased
44
Reduced
23
Closed
14
Calls
$2.89M
Puts
$6.1M
Net Calls
-$3.21M
Net Calls Change
-$3.6M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$85.4M
2
BlackRock
BlackRock
New York
+$79.6M
3
Artisan Partners
Artisan Partners
Wisconsin
+$40.6M
4
HA
HHLR Advisors
Cayman Islands
+$38M
5
State Street
State Street
Massachusetts
+$27.5M

Top Sellers

1
MICM
Matthews International Capital Management
California
-$17.8M
2
VC
Vivo Capital
California
-$12.4M
3
APM
Avidity Partners Management
Texas
-$9.24M
4
AA
ALPS Advisors
Colorado
-$8.96M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$4.77M +$2.32M +45,748 +81%
GCM
52
Ghisallo Capital Management
Massachusetts
$4.66M +$5.07M +100,000 New
Bank of America
53
Bank of America
North Carolina
$4.54M +$4.72M +93,071 +2,174%
N
54
Nuveen
North Carolina
$4.34M +$4.73M +93,220 New
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$4.28M +$4.65M +91,736 New
TLP
56
Tri Locum Partners
New York
$4.19M -$3.99M -78,627 -47%
ACH
57
ArrowMark Colorado Holdings
Colorado
$4.09M – – –
OWP
58
Old Well Partners
North Carolina
$3.71M +$4.04M +79,700 New
Vanguard Group
59
Vanguard Group
Pennsylvania
$3.63M +$3.95M +77,816 New
EAM
60
EFG Asset Management
Oregon
$3.62M +$3.94M +77,718 New
Sumitomo Mitsui Trust Group
61
Sumitomo Mitsui Trust Group
Japan
$3.49M +$3.79M +74,796 New
National Bank of Canada
62
National Bank of Canada
Quebec, Canada
$3.32M +$3.62M +71,300 New
AP
63
AtonRa Partners
Switzerland
$2.93M +$1.49M +29,356 +88%
Invesco
64
Invesco
Georgia
$2.7M +$2.94M +57,949 New
Citigroup
65
Citigroup
New York
$2.34M +$1.75M +34,543 +222%
ACM
66
Altium Capital Management
New York
$2.33M +$2.54M +50,000 New
CCM
67
CAAS Capital Management
New York
$2.16M +$2.35M +46,334 New
PAMS
68
Pictet Asset Management (Switzerland)
Switzerland
$2.11M +$2.3M +45,344 New
Swiss National Bank
69
Swiss National Bank
Switzerland
$1.94M +$2.11M +41,600 New
AAF
70
Andra AP-fonden
Sweden
$1.85M +$2.01M +39,600 New
Two Sigma Investments
71
Two Sigma Investments
New York
$1.82M +$1.98M +38,972 New
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$1.52M +$1.66M +32,647 New
HSBC Holdings
73
HSBC Holdings
United Kingdom
$1.49M +$1.62M +31,953 New
Bank of New York Mellon
74
Bank of New York Mellon
New York
$1.48M +$1.61M +31,800 New
CSS
75
Cubist Systematic Strategies
Connecticut
$1.43M -$1.25M -24,583 -45%
1 2
3
4 5

LEGN Hedge Fund Activity: Q4 2021 in Review

139 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2021, worth a combined $2.33B — up 18% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new LEGN positions and 14 closed out — a net gain of 52 holders — while 44 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $85.4M. The largest seller was Matthews International Capital Management, cutting an estimated $17.8M.

  • 139 institutional investors held Legend Biotech (LEGN) as of Q4 2021, up from 88 in Q3 2021.
  • Funds reported $2.33B of Legend Biotech stock for Q4 2021, up 18% quarter-over-quarter.
  • 66 funds opened new Legend Biotech positions in Q4 2021 and 14 closed out, a net change of +52 holders.
  • The largest Legend Biotech buyer in Q4 2021 was Wellington Management Group, an estimated $85.4M added.
  • The largest Legend Biotech seller in Q4 2021 was Matthews International Capital Management, an estimated $17.8M sold.

Based on aggregated 13F filings for Q4 2021.